The latest government showdown over the budget risks not only a shutdown but jobs, regional economies and America’s competitiveness in AI and other advanced fields.
Drug development takes a great deal of time, money and effort. While future profits play a big factor in which diseases gets prioritized, advocacy and research incentives can also tilt the scale.
UK scientists are now participating in fewer collaborations with European research teams.
A new screening tool to help study reviewers identify what’s fake or shoddy in research may be on the horizon. And everyday people can apply some of the same critical analysis tools.
Tay-Sachs is a rare and fatal neurodegerative disorder that most commonly affects children. Researchers have developed the first Tay-Sachs treatment to reach clinical trials.
If no action is taken to address antibiotic resistance, infections from multidrug-resistant bacteria could cause 10 million deaths each year by 2050.
Islamophobia increased post-9/11. Twenty years later, American Muslims are still dealing with the mental health effects – and research barriers limit what is known about what puts them at risk.
History of Science Professor Naomi Oreskes examines the power of funding to shape science, for both better and worse, in her latest book, “Science on a Mission: How Military Funding Shaped What We Do and Don’t Know about the Ocean.”
A more coordinated effort by scientists, stakeholders and community members will be required to stop the next deadly virus that's already circulating in our midst.
The recent arrest of a Chinese-born scientist at MIT raises questions about the value of international science collaboration and its impact on the American innovation system.
/
2
